Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PFDN2 |
| Upstream (Parents) |
|---|
| (<<) CIRH1A → PFDN2 |
| (<<) CSTB → PFDN2 |
| (<<) CYP2U1 → PFDN2 |
| (<<) GALK1 → PFDN2 |
| (<<) HOPX → PFDN2 |
| (<<) KLF6 → PFDN2 |
| (<<) LYAR → PFDN2 |
| (<<) MTAP → PFDN2 |
| (<<) PPIF → PFDN2 |
| (<<) PRKCH → PFDN2 |
| (<<) RRP9 → PFDN2 |
| (<<) SEH1L → PFDN2 |
| (<<) SLC25A37 → PFDN2 |
| (<<) TAGLN2 → PFDN2 |
| (<<) THOC4 → PFDN2 |
| (<<) UBE2C → PFDN2 |
| Downstream (Children) |
|---|
| PFDN2 → BBS1 (>>) |
| PFDN2 → E2F5 (>>) |
| PFDN2 → FZD9 (>>) |
| PFDN2 → GAL (>>) |
| PFDN2 → JMJD6 (>>) |
| PFDN2 → POP1 (>>) |
| PFDN2 → PRDX6 (>>) |
| PFDN2 → PTPMT1 (>>) |
| PFDN2 → RPS6KA5 (>>) |
| PFDN2 → RRAS2 (>>) |
| PFDN2 → SLC25A32 (>>) |
| PFDN2 → TAF1A (>>) |
